Company Filing History:
Years Active: 2018-2020
Title: Innovations by Inventor Chul Woo Yang in Immunomodulation
Introduction
Chul Woo Yang is a prominent inventor based in Seoul, South Korea, known for his contributions to the field of immunology and stem cell therapy. With a total of two patents to his name, his work focuses on developing innovative approaches to treat immune disorders through the use of modified mesenchymal stem cells.
Latest Patents
Yang's latest patents include a significant innovation: "MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders." This invention pertains to the development of a mesenchymal stem cell with enhanced immunomodulatory properties achieved through rapamycin treatment. The cells express specific surface factors such as CCR1, CCR2, and others, while exhibiting increased levels of IDO, TGF-β, and IL-10, which are crucial for immunomodulation. Additionally, he has developed a composition for alleviating nephrotoxicity caused by immunosuppressive drugs, specifically comprising metformin, aimed at improving treatment outcomes for individuals requiring immunosuppression.
Career Highlights
Throughout his career, Chul Woo Yang has been affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation, where he has contributed to advancing research in immunomodulatory therapies. His background in stem cell research has positioned him as a key figure in the development of innovative solutions for managing immune disorders and enhancing treatment protocols.
Collaborations
Yang has collaborated with esteemed colleagues such as Eun Kyung Kim and Min Jung Park, who have complemented his research efforts in the development of novel therapies. These collaborations have played a vital role in progressing his innovative work and expanding the impact of his inventions in the scientific community.
Conclusion
Chul Woo Yang's pioneering work in the field of immunology showcases the potential of modified stem cells to revolutionize the treatment of immune disorders. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes through groundbreaking research and collaboration.